Parnax Lab Quarterly Results for Trading Insights
PARNAXLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹4 Cr
QSept 2025
Parnax Lab Quarterly Results Key Highlights
- Revenue of ₹63 Cr in Sept 2025 (+26.0% vs Mar 2025, +28.6% vs Sept 2024)
- Net Profit of ₹4 Cr in Sept 2025 (+33.3% vs Mar 2025, +33.3% vs Sept 2024)
- EBITDA of ₹9 Cr in Sept 2025 (+28.6% vs Mar 2025)
- Operating Margin of 13.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹3.15 in Sept 2025 (+23.5% vs Mar 2025)
Parnax Lab Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 63 | 50 | 54 | 49 | 47 | 26.0% | 28.6% |
| Net Profit (₹ Cr) | 4 | 3 | 3 | 3 | 2 | - | - |
| EBITDA (₹ Cr) | 9 | 7 | 8 | 8 | 6 | - | - |
| EPS (₹) | 3.15 | 2.55 | 2.85 | 2.97 | 1.95 | - | - |
| Operating Margin (%) | 13.0% | 14.0% | 14.0% | 15.0% | 13.0% | - | - |
Parnax Lab Share Price Trend Around Quarterly Results
Visualize Parnax Lab's 1-year price movement across quarterly results — ideal for logging trades in Parnax Lab share price
chart using Tickjournal. All values in ₹.
Related Pages for Parnax Lab
Additional stock information and data for PARNAXLAB
Revenue Trend (₹ Cr)
Sept 2024
49
Jun 2025
54
Mar 2025
50
Sept 2025
63
Net Profit Trend (₹ Cr)
Sept 2024
3
Jun 2025
3
Mar 2025
3
Sept 2025
4
Operating Margin Trend (%)
Sept 2024
15.0%
Jun 2025
14.0%
Mar 2025
14.0%
Sept 2025
13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Parnax Lab quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores